Heart Transplantation

About the Program  |  Congestive Heart Failure  |  Treatment Options  |  Eligibility  |  Expectations  |  Our Team  |  Patient Resources

About the Program

The Hartford Hospital Transplant Program was established in 1984. It was founded and developed by Dr. Henry B.C. Low. The center is under the direction of Dr. Patricia Sheiner, Director of Transplant Services; Dr. Jonathan A. Hammond, Surgical Director; and Dr. James E. Dougherty, Medical Director.

The program has grown tremendously over the years. It is Medicare certified and continues to have results at or above national standards. In addition, the Heart Transplant Program has a full left ventricular assist device capability and implantable heart mate capability as a bridge to transplantation.

Most transplant candidates are referred from Western Massachusetts, New York and Connecticut by their primary care physician or local cardiologist. Many also enter at their own initiative.

A program that changes lives
Hartford Hospital’s Transplant Program has saved and greatly improved the lives of hundreds of people in recent years. By replacing organs that have ceased to function effectively, the program has given new life, new energy, and new possibilities to people whose lives have been restricted by debilitating conditions.

We have worked to build a team of committed and gifted physicians, nurses, researchers, counselors, and social worker whose special expertise guarantees that our patients receive the best treatment available. We are dedicated to providing the comprehensive care from the time a patient is referred and indefinitely after the transplant.

Back to Top

Understanding Congestive Heat Failure

Congestive heart failure occurs when the weakened heart muscle loses its ability to pump efficiently. For nearly five million aging Americans, congestive heart failure brings frightening trips to the emergency room and recurrent hospitalizations. In the United States, 550,000 new cases of CHF are diagnosed each year. The condition usually develops gradually as the result of a heart attack, uncontrolled high blood pressure, heart defect or viral infection.

During a heart attack, a sudden clot blocks a coronary artery, sometimes damaging the oxygen-starved heart muscle permanently. When the heart can’t pump forcefully enough, blood flow drops as the heart struggles to supply oxygen and nutrients to the brain and vital organs. The chambers of the heart stretch to hold more blood, but over time, the heart muscle walls weaken and pumping slows. The kidneys respond by causing the body to retain water and sodium. Blood backs up into the veins leading to the heart, excess fluid pools in the lower legs and ankles, and the belly becomes swollen and congested. Fluid fills the lungs, causing shortness of breath, especially when lying down.

When so much fluid accumulates that diuretics (water pills) no longer work, the usual treatment is hospitalization for intravenous (IV) administration of medications. In hospitals across the country, congestive heart failure is the leading cause of hospitalization for patients age 65 and over.

Nationally, the average stay for CHF patients is five to six days—and 50 percent are readmitted to the hospital within six months. Outpatient infusions have been shown to reduce hospital readmissions by as much as 91 percent.

At Hartford Hospital, our results show that outpatient infusion with IV diuretics keeps heart failure patients mobile, which translates into better outcomes. Patients referred to us by a cardiologist can call and come directly to the infusion center, avoiding the emergency department and hospitalization.

Back to Top

Treatment Options

Ventricular Assist Devices (VADs)

Hartford Hospital is well-experienced in the use of VADs for potential transplant patients.

VADs are implantable mechanical heart pumps. They have been used for many years to sustain patients who are candidates for heart transplant as they await a donor heart. With the development of lighter, more dependable VADs, it has become possible to consider the use of these devices not only as a "bridge to transplant," but as a stand-alone therapy for those with hearts too weak to function properly.

Emerging research suggests what was once thought impossible: Some VAD patients find that their hearts actually improve with help from these mechanical pumps.

Right Ventricular Impella Device

The right ventricular Impella device (a "mini heart") is designed to support patients with right ventricular dysfunction that is usually associated with an inferior wall marked cardial infarction. The presently available support devices including balloon pumps, Impella, and tandem heart are useful to support a failing left ventricle but provide no right ventricular support. The right heart Impella is a catheter that is placed from the inferior vena cava through the right atrium, right ventricle and is positioned in the pulmonary artery. There is a pump within this catheter. It withdraws blood from the inferior vena cava and pumps into the pulmonary artery (thus taking over the function of the right ventricle).

Left Ventricle Assist Devices

The TCI Heartmate Left Ventricle Assist Device is a mechanical circulatory support system and can serve as a bridge to transplantation. The use of the Heartmate including enhanced intra-operative technique allows patients to be in better condition for transplantation.

In addition to the Hearmate LVAD, Hartford Hospital has the TCI Vented Electric Heartmate implantable LVAD as a bridge to transplantation. This device is powered by a portable battery pack, which allows patients greater mobility with the potential, when medically stable, for patients to go home on the device while waiting for their transplant.

During the initial stages of evaluation, the patient undergoes many tests and sees many specialists. This is also the time when the patient is first introduced to the support network. The transplant coordinators, social worker, and Financial Coordinator play an extremely important role in providing this support.

Heart Failure Infusion Center

In addition to cutting-edge VAD options, Hartford Hospital’s new heart failure infusion center is changing the way today’s patients live with heart disease. This state-of-the-art outpatient treatment facility is dedicated to caring for patients at the advanced stage of heart failure. Intravenous administration of medications rapidly improves symptoms and restores normal fluid status. The program's comprehensive heart disease management includes nutritional counseling designed to help patients adhere to a complex medical regimen and a specialized low-sodium diet. Patients learn to recognize weight gain that signals fluid retention. Cardiac rehabilitation and individualized exercise plans strengthen the heart muscle to improve circulation and support the recovery process.

Heart Transplantation

In general, pediatric and adult patients with advanced irreversible heart failure, on maximal medical therapy with a limited life expectancy should be considered for transplantation evaluation. Patients with increasing medication requirements, frequent hospitalizations or overall deterioration of clinical status should be considered.

The causes of congestive heart failure that result in heart transplantation are primary cardiomyopathy, coronary artery disease, or inoperable ischemic coronary disease with arrhythmias. A small percentage of patients who undergo heart transplantation do so for valvular heart disease, congenital heart disease, and inoperable hypertrophic cardiomyopathy.

Back to Top

Eligibility for Heart Transplantion

In general, patients with advance heart failure, or on maximal medical therapy, should be considered for transplant evaluation. Patients with increasing medication requirements, frequent hospitalizations, or overall deterioration of clinical status should be referred for evaluation. Some causes of heart failure that result in cardiac transplantation are primary cardiomyopathy, coronary artery disease, with either resultant ischemic cardiomyopathy and symptoms of congestive heart failure or inoperable ischemic heart disease with refractory chest discomfort or arrhythmia. A small percentage of patients who undergo cardiac transplantation do so for idiopathic dialated cardiomyopathy, valvular heart disease, congenital heart disease and inoperable hypertrophic cardiomyopathy.

All candidates for transplantation enter the program with a comprehensive series of tests conducted by our multidisciplinary team of specialists. Some of these tests are required for any operative procedure (history and physical chest x-ray EKG etc.) while others (such as specific blood tests) are required for transplantation surgery.

Once the evaluation is complete, the transplant team will recommend treatment options and discuss if heart transplant is the best option. The risks and benefits will be discussed with each patient. After a candidate is accepted for transplantation, the patient is then placed on the national transplant waiting list maintained by the United Network for Organ Sharing (UNOS). Depending on the blood group, the average waiting time on our list is currently less than 12 months. The time may be shorter or longer depending on the donor supply and the patient waiting list. While waiting, the patient is followed in the office periodically to assist with any medical issues that may arise.

The Transplant Coordinators are involved in the pre-transplant screening and stay involved throughout the years of follow-up care. In this way, patients benefit from having the same people throughout their participation in the program. Our patients tell us that the transplant coordinators, because of the range of their involvement and the depth of their concern, are essential participants in the support network.

Our social worker is a resource, advocate and a link between patients and all the services designed to assist them. The social worker helps patients and their families address the many complex social and personal that arise for transplant patients. The services range from helping with personal and psychological issues that result from living with a chronic medical condition, to lodging, joining support groups and receiving vocational rehabilitation.

The Financial Coordinator assists patients with financial and insurance issues related to transplantation. The services include assessing patient insurance for hospital and pharmacy benefits, identifying and attempting to resolve patient financial problems, and helping patients in requesting and applying for assistance from transplant resource programs.

A suitable heart transplant candidate should at a minimum meet the following criteria:

  • Cardiac disease, NYHA advanced Class III or Class IV;
  • Condition is not amenable to other forms of medical or surgical therapy;
  • Endstage cardiac disease with less than a 25% likelihood of survival at one year without a transplant.
  • Patients with potentially fatal arrhythmia not amenable to other therapies.

It is important that candidates be in, otherwise, good health and be without serious medical illness.

Factors That Can Rule Out Heart Transplantation

Relative Factors:

  • Unusual weight loss
  • Drug or alcohol abuse
  • Cigarette smoking
  • Advanced age (over 65 years). However, the physiological age of the candidate rather than the chronological age is the major consideration.
  • Severe cachexia.
  • Psychiatric illness which may interfere with compliance.
  • Morbid obesity.
  • Advanced, generalized atherosclerosis; severe peripheral vascular disease.
  • Diabetes Mellitus in poor control.
  • History of cancer (detailed information needed for evaluation).

Absolute Factors:

  • Fixed pulmonary hypertension (as reflected by a calculated pulmonary resistance above 6 Wood units, or a pulmonary arteriolar gradient greater than 15mm.)
  • Active systemic infection
  • Severe cerebral or carotid vascular disease not amenable to surgery
  • Severe chronic obstructive pulmonary disease or severe chronic bronchitis
  • Irreversible and severe hepatic or renal dysfunction (unless combined transplant is possible)
  • Active Malignancy
  • Unmanageable and/or severe psychiatric disease
  • The patient (or parent if the patient is a child) is unable to understand the issues related to transplant and unable or unwilling to take medications as instructed
  • Active peptic ulcer disease
  • Substance addictions including tobacco use

Back to Top

Expectations After Heart Transplant Surgery

When a compatible organ becomes available, the transplant patient is immediately contacted by a transplant coordinator or transplant surgeon and admitted to the hospital. At this time, a history is taken of any medical events, which may have occurred since initial transplant evaluation. All appropriate testing is also done to ensure the patient’s readiness for surgery.

The surgery lasts approximately five to eight hours. When the surgery is completed, the patient is transferred to the Cardiac Intensive Care Unit. Once stable, the patient is transferred to the transplant patient care unit on North 11.

The average length of stay in the ICU is 3-7 days. The average total length of stay in the hospital is 2-3 weeks.

Careful, comprehensive post-surgical monitoring constantly evaluates whether the body is accepting the new organ. Patient education is a major focus of the post transplant care. Patients must understand their medical regimen and be responsible for their follow-up care.

Outpatient Visit
Follow-up care initially involves returning to the Hartford Hospital Transplant Program office several times per week during the first month after leaving the hospital. A series of blood tests and occasionally biopsies are conducted to closely monitor the patient’s progress. This is a period when medications are precisely adjusted to reach a point of effective stability. As time goes on, blood tests and office visits are extended. Monthly blood tests and three-month office visits are required indefinitely.

The Patient’s Responsibility
While transplantation can greatly improve the recipients’ quality of life, it also demands much of them. Recipients must become active participants in preserving their health. In addition to regular follow-up, patients must call the Hartford Hospital Transplant Program office with any concerns or questions that they have about their health. For the rest of their lives, they must take their medications especially immunosuppression (anti-rejection) medications.

Immunosuppressive Medication
Transplantation has become increasingly successful in recent years in large part through the development of new, more effective drugs that prevent the body from rejecting the donated organs. These drugs inhibit the body’s immune system from identifying the new organ as foreign. It is necessary for all patients to take immunosuppressive medication for the rest of their lives following the transplant. A successful transplant can be undermined very quickly if patients fail to take their medications appropriately and responsibly.

Back to Top

  • Liver Transplantation

    The Hartford Hospital Transplant Program performed its first Liver Transplant operation in November, 1984.

  • Transplantation Resources

    Additional transplantation resources.

  • Advancing Medicine

    Click to learn how Hartford Hospital is advancing transplant medicine.

  • Kidney Transplantation

    The Kidney Transplant Program at Hartford Hospital was established in 1971 and is one of the oldest and most successful in New England.

  • Linda's Story

    Click to watch Linda's story.

  • Organ Donations

    Each year, the number of end stage renal disease (ESRD) patients waiting for a transplant increases.

  • Maggie's Story

    Click to watch Maggie's Story.

  • Kevin's Story

    Click to watch Kevin's Story.

  • Heart Transplantation

    The Hartford Hospital Transplant Program was established in 1984.

  • Liver Transplant Team

    The goal of the Hartford Hospital Liver Transplantation Team is to restore patients with advanced liver disease to their optimum level of health and to return them to a productive life.

  • Kidney Transplant Team

    The Kidney Transplant Program team is committed to providing supportive and respectful patient centered care and knows the most important member of the team is the patient.

  • Heart Transplant Team

    We have worked to build a heart transplant team consisting of committed and gifted physicians, nurses, researchers, counselors, and social workers whose special expertise guarantees that our patients receive the best treatment available.

Heart Transplant Program